Skip to content
Open access

RGS Family Remodeling in Breast Cancer: A Meta‐Analysis and Multi‐Omics Profiling of Prognostic Biomarkers

Jul 2026 · Cancer Medicine · Vol 15 · 0 citations · 79 references
Medicine

TL;DR

This study systematically investigated the RGS family to identify potential biomarkers and therapeutic targets in breast cancer and identified potential biomarkers and therapeutic targets that improve prognosis in subsets of patients.

Abstract

Breast cancer (BC) is a heterogeneous malignancy with diverse molecular subtypes and variable clinical outcomes. Despite diagnostic and therapeutic advances, recurrence and metastasis contribute to poor prognosis in subsets of patients. Regulators of G protein signaling (RGS) proteins, negative modulators of G protein‐coupled receptor (GPCR) pathways, influence tumor progression, but their expression profiles, genomic alterations, immune associations, and prognostic roles in BC remain incompletely understood. This study systematically investigated the RGS family to identify potential biomarkers and therapeutic targets.

Read PDF

Similar papers

Open access Sep 2026

Identification of lncRNAs in Breast Cancer Through Bioinformatics Analysis: Implications for Pathogenesis and Prognostic Significance

Breast cancer (BC) is a disease with a subtle onset, often diagnosed late, and has a high mortality rate. This study aimed to identify long non‐coding RNAs (lncRNAs) linked to BC as prognostic markers using bioinformatics and initial experiments, explore their regulatory pathways, and assess their expression and progno...

Yu-Han Zheng, Xing-Gui Chen, Xuan Liu et al. · 0 citations
Open access Sep 2026

Comprehensive In Silico Analysis Identifies MSTO1 and LIG1 as Candidate Biomarkers With Diagnostic and Prognostic Relevance in Hepatocellular Carcinoma

This work has shown that novel molecular markers with improved sensitivity, specificity, and therapeutic relevance are essential for enhancing early detection and guiding personalized treatment strategies in HCC.

Jana Hamad, Hussein Fayyad-Kazan, F. Abdel-Sater · 0 citations
Aug 2026

Comprehensive analysis of senescence-associated secretory phenotype-related signature for predicting prognosis and immunotherapy response in cervical cancer.

Cervical cancer (CESC) is a common malignancy in women. The senescence-associated secretory phenotype (SASP) contributes to tumor progression. We developed and validated a 7-gene SASP-related prognostic signature (PTPRB, RBM38, WNT3A, TNF, SPP1, ROR1, and MEIS2) using TCGA and GEO datasets. Patients in the low-risk gro...

Yao Fu, Li Du, Haiyan Zhang et al. · 0 citations
Open access Sep 2026

Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy

Colorectal cancer (CRC) remains a leading cause of cancer mortality. This study investigates the prognostic and immunological role of neural-related genes (NRGs) in CRC. Using The Cancer Genome Atlas (TCGA) data, a four-gene signature (POU4F1, KLC3, ATP2A1, CALB2) was constructed via Cox and least absolute shrinkage an...

Huan-Tong Wu, Wei-Hua Liu, Sheng-Tao Zhu · 0 citations
Open access Sep 2026

Neutrophil-related gene signature predicts prognosis and immune microenvironment patterns in thyroid cancer.

BACKGROUND Thyroid carcinoma (THCA) represents the most prevalent malignancy of the endocrine system. Although the majority of patients exhibit favorable clinical outcomes, a subset still faces significant clinical challenges, including distant metastasis, recurrence, and poor response to therapeutic interventions, all...

Liang Chen, Chao-Hon Fu, Yang Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.